Equity Research to Corporate Venture Capital or VC; Pipedream or Attainable?

Currently covering non-pharma healthcare and really like the IT, Life Science and MedTech side of healthcare. I've known for some time that buy-side isn't what I want, and have been interested in the corporate side of finance. What I found even more interesting was some corporate entities have a venture arm that invest off the parents balance sheet, but is often tied with Corporate / Business Development or Strategy (even saw some Market / Competitive Intelligence too). 

Coming from research, I don't have any deal experience but do know the space and have good modeling / writing skills. I'm also really interested in how teams looks at founders and the discussion that goes on between the two parties. Question I have is, is it possible for someone in ER to go to CVC or VC in the space already covered? Is there anything I can do to better position myself to be an attractive candidate?

2 Comments
 
Most Helpful

I'd venture to say yes. Big asset is knowing the industry , trends, players, key levers, key needs and pain points, how and where can be made money in the space etc. Not sure how much exposure you've had to private companies in the space, so there you may need to dig deeper: key companies in growth and early stage, what and how are they doing, founding teams, what it takes them to successfully scale, moats and how they can be eroded, etc.

In addition, it would be important for you to articulate the investment side. This is rather generic and easy to learn: key concepts, what makes a deal a good deal (good company not necessarily a good deal), mechanics and key terms. Pretty standard stuff 

The insights you can bring from the industry married with investment insights (not experience, but understably as you haven't invested) are key here.

Cherry on top: find ways to expand your exposure (starup events, ideally in those verticals, sessions with founders) and ways to improve your chops (serving as sparring partner for startups or angels, etc).

Good luck, tell us how it evolves!!

 

Hic iste ex ut sed enim. Sunt sed nam perspiciatis excepturi. Quo perspiciatis quia eligendi omnis totam. Velit ab illo sit non atque sed. Ab officiis qui expedita aut atque nihil veritatis. Assumenda laboriosam culpa facere et rerum quidem.

Molestiae illo eveniet quia voluptate totam eos. Temporibus corporis eius aut quae.

Aut consequatur dolores saepe laborum rerum odio id. Cum molestias autem aspernatur aut consequatur enim nihil. Quasi consequatur dolor harum in laborum illum. Ratione rerum blanditiis dolor quia voluptas consequatur.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.8%
  • Morgan Stanley 07 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.7%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”